1 Bielory L, "Therapeutic targets in allergic eye disease" 22 : 25-28, 2001
2 Lee JS, "The effects of artificial tear formulation and anti-inflammatory agents on the cultured keratocyted of rabbit" 39 : 42-51, 1998
3 Freshney RI, "The culture environment: Substrate, gas phase, medium, and temparature, 2nd ed" Wiley-Liss 70-71, 1987
4 Sarac OI, "Tear eotaxin levels in giant papillary conjunctivitis associated with ocular prosthesis" 11 : 223-230, 2003
5 Mosmann TJ, "Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays" 65 : 55-63, 1983
6 Spangler DL, "Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models" 25 : 2245-2267, 2003
7 Burstein NL, "Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas" 19 : 308-313, 1980
8 Park YS, "Physiology of body fluid. In Physiology, 5th ed" Sin-Kwang publishing & printing 5-, 2000
9 Schultz BL, "Pharmacology of ocular allergy" 6 : 383-389, 2006
10 Abelson MB, "Ocular allergic disease: Mechanisms, disease sub-types, treat" 1 : 127-149, 2003
1 Bielory L, "Therapeutic targets in allergic eye disease" 22 : 25-28, 2001
2 Lee JS, "The effects of artificial tear formulation and anti-inflammatory agents on the cultured keratocyted of rabbit" 39 : 42-51, 1998
3 Freshney RI, "The culture environment: Substrate, gas phase, medium, and temparature, 2nd ed" Wiley-Liss 70-71, 1987
4 Sarac OI, "Tear eotaxin levels in giant papillary conjunctivitis associated with ocular prosthesis" 11 : 223-230, 2003
5 Mosmann TJ, "Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays" 65 : 55-63, 1983
6 Spangler DL, "Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models" 25 : 2245-2267, 2003
7 Burstein NL, "Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas" 19 : 308-313, 1980
8 Park YS, "Physiology of body fluid. In Physiology, 5th ed" Sin-Kwang publishing & printing 5-, 2000
9 Schultz BL, "Pharmacology of ocular allergy" 6 : 383-389, 2006
10 Abelson MB, "Ocular allergic disease: Mechanisms, disease sub-types, treat" 1 : 127-149, 2003
11 Leonardi A, "Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures" 36 : 777-784, 2006
12 Frossard N, "Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine" 65 : 172-179, 2007
13 Green K, "Influence of various agents on corneal permeability" 72 : 897-905, 1971
14 Holgate ST, "Improving the management of atopic disease" 90 : 826-831, 2005
15 Foster CS, "Immunologic disorders of the conjunctiva, cornea, and sclera In Principles and Practice of Ophthalmology" WB Saunders Company 65-, 1994
16 Luo L, "Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface" 31 : 186-193, 2005
17 Weeke ER, "Epidemiology of hay fever and perennial allergic rhinitis" 21 : 1-20, 1987
18 Wee RW, "Effect of anrtificial tears on cultured keratocytes in vitro" 14 : 273-279, 1995
19 Lee JS, "Cytotoxicity of banzalkonium chlorid on the corneal epithelial cell of rabbit" 39 : 1326-1333, 1998
20 Cha SH, "Corneal epithelial cellular dysfunction from banzalkonium chloride (BAC) in vitro" 32 : 180-184, 2004
21 Lee JS, "Comparison of the conjunctival toxicity of topical ocular antiallergic agents" 24 : 557-562, 2008
22 Lee SJ, "Body fluid and acid-base balance. In Physiology" Eui-hak publishing & printing 20-, 2002
23 McGill JI, "A review of the use of olopatadine in allergic conjunctivitis" 25 : 171-179, 2004